The findings illustrated that the prognostic module with ABHD11-AS1, in combination with other clinical indicators, such as ER, PR, HER2, and TNM, have high accuracy and sensitivity for breast cancer risk-stratification (C-index = 0.868). Here, ERBB2 is linked to breast carcinoma.